Biochemical evaluation of the patient with osteoporosis;Exploration biologique des pathologies osseuses et en particulier des ostéoporoses

Immuno-Analyse et Biologie Specialisee

Volumn 18, Issue 2, 2003, Pages 92-97

  Souberbielle, J C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Bone markers; Calcium; Osteoporosis; Parathyroid hormone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; CALCIUM; CORTICOSTEROID; ESTROGEN; ETIDRONIC ACID; MARKER; PARATHYROID HORMONE; PHOSPHATE; RALOXIFENE; RISEDRONIC ACID; VITAMIN D;

AGING; AMENORRHEA; ANOREXIA; ARTICLE; BONE DENSITY; BONE DISEASE; BONE REMODELING; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; DENSITOMETRY; EVALUATION; FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPERADRENOCORTICISM; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOGONADISM; IMMOBILIZATION; KIDNEY FUNCTION; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PAGET BONE DISEASE; PATHOPHYSIOLOGY; PATIENT; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SECONDARY OSTEOPOROSIS; SUPPLEMENTATION;

EID: 1042287328     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(03)00024-3     Document Type: Article

References (14)

1. Bjarnason N.H., Sarkar S., Duong T., Mitlak B., Delmas P., Christiansen C. Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporosis Int. 12:2001;922-930.
2. Delmas P., Eastell R., Garnero P., Seibel M., Stepan J. The use of biochemical markers of bone turnover in the management of post-menopausal osteoporosis. Osteoporosis Int. 11:(Suppl 6):2000;2-17.
3. Garnero P., Bianchi F., Carlier M.C., Genty V., Kamel S., Kindermans C., Plouvier E., Pressac M., Souberbielle J.C. Les marqueurs biologiques du remodelage osseux: variations pré-analytiques et recommandations pour leur utilisation. Ann Biol Clin. 58:2000;683-704.
4. Kleerekoper M. Evaluation of the patient with osteoporosis or at risk for osteoporosis. Marcus R., Feldman D., Kelsey J. Osteoporosis. 2nd:2001;Academic Press, San Diego, Ca.
5. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Reviews. 22:2001;477-501.
6. Mallette L., Kirkland L., gagel R., Law W., Heath H. Synthetic human parathyroid hormone (1-34) for the study of pseudohypoparathyroidism. J Clin Endocrinol metab. 67:1988;964-972.
7. Miller P., Baran D., Bilezikian J., Greenspan S., Lindsay R., Riggs L., Watts N. Practical applications of biochemical markers of bone turnover. Consensus of an expert panel. J Clin Densitometry. 2:1999;323-342.
8. Nishizawa Y., Nakamura T., Ohata H., Kushida K., Gorai I., Shiraki M., Fukunaga M., Hosoi T., Miki T., Nakatsuka K., Miura M. Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001). J Bone Miner Metab. 19:2001;338-344.
9. Nuti R., Martini G., Valenti R., Giovani S., Salvadori S., Avanzadi A. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern M. 250:2001;361-366.
10. Randall A.G., Kent G.N., Garcia-Webb P., Bhagat C.I., Pearce D.J., Gutteridge D.H., Prince R.L., Stewart G., Stuckey B., Will R.K., Retallack R.W., Price R.I., Ward I. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res. 11:1996;1176-1184.
11. Souberbielle J.C., Cormier C., Kindermans C., Gao P., Cantor T., Forette F., Baulieu E.E. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab. 86:2001;3086-3090.
12. Souberbielle J.C., Carlier M.C., Bianchi F., genty V., jacob N., jamel S., Kindermans C., Plouvier E., Pressac M., Garnero P. Enquête sur la prescription des marqueurs du remodelage osseux en milieu hospitalier. Ann Biol Clin. 60:2002;571-579.
13. Tannenbaum C., Clark J., Schwartzman K., Wallenstein S., Lapinsky R., Meier D., Luckey M. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 87:2002;443 1-44437.
14. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr. 69:1999;842-856.